Home/Filings/4/0001144204-19-005092
4//SEC Filing

WENTZ MYRON W 4

Accession 0001144204-19-005092

CIK 0000896264other

Filed

Feb 4, 7:00 PM ET

Accepted

Feb 5, 5:26 PM ET

Size

19.7 KB

Accession

0001144204-19-005092

Insider Transaction Report

Form 4
Period: 2019-02-01
Transactions
  • Sale

    Common Stock

    2019-02-01$114.34/sh8,662$990,4139,886,952 total(indirect: Shares owned of record by Gull Global Limited)
  • Sale

    Common Stock

    2019-02-01$115.57/sh2,910$336,3099,884,042 total(indirect: Shares owned of record by Gull Global Limited)
  • Sale

    Common Stock

    2019-02-01$116.20/sh8,354$970,7359,875,688 total(indirect: Shares owned of record by Gull Global Limited)
  • Sale

    Common Stock

    2019-02-04$116.90/sh800$93,5209,865,614 total(indirect: Shares owned of record by Gull Global Limited)
  • Sale

    Common Stock

    2019-02-04$114.19/sh1,400$159,8669,873,569 total(indirect: Shares owned of record by Gull Global Limited)
  • Sale

    Common Stock

    2019-02-01$116.97/sh719$84,1019,874,969 total(indirect: Shares owned of record by Gull Global Limited)
  • Sale

    Common Stock

    2019-02-04$115.32/sh2,600$299,8329,870,969 total(indirect: Shares owned of record by Gull Global Limited)
  • Sale

    Common Stock

    2019-02-04$116.32/sh4,555$529,8389,866,414 total(indirect: Shares owned of record by Gull Global Limited)
Footnotes (12)
  • [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  • [F10]Weighted average price. Price range in multiple transactions was $115.82 to $116.76, inclusive.
  • [F11]Weighted average price. Price range in multiple transactions was $116.82 to $117.00, inclusive.
  • [F12]The total number of outstanding shares reflects 300 shares fewer than the total number of shares last reported as beneficially owned on a Form 4 filed on January 4, 2019, which 300 shares were sold on January 4, 2019, at an average weighted price of $115.00, with actual prices ranging from $114.71 to $115.67 (and were in addition to the sales reported on the Form 4 filed on January 4, 2019).
  • [F2]Weighted average price. Price range in multiple transactions was $113.94 to $114.93, inclusive.
  • [F3]The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth.
  • [F4]The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz.
  • [F5]Weighted average price. Price range in multiple transactions was $114.94 to $115.93, inclusive.
  • [F6]Weighted average price. Price range in multiple transactions was $115.94 to $116.80, inclusive.
  • [F7]Weighted average price. Price range in multiple transactions was $116.94 to $117.10, inclusive.
  • [F8]Weighted average price. Price range in multiple transactions was $113.70 to $114.68, inclusive.
  • [F9]Weighted average price. Price range in multiple transactions was $114.82 to $115.81, inclusive.

Issuer

USANA HEALTH SCIENCES INC

CIK 0000896264

Entity typeother

Related Parties

1
  • filerCIK 0001203301

Filing Metadata

Form type
4
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 5:26 PM ET
Size
19.7 KB